Breakdown of Pulmonary Host Defense in the Immunocompromised Host Cancer Chemotherapy Ladina Joos and Michael Tamm Pulmonary Medicine and Pulmonary Cell...
Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia. YL...
11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of...
What is the current evidence for antigen involvement in the development of chronic lymphocytic leukemia? Gerard Tobin, Anders Rosen, and Richard Rosenquist ...
Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. K Mehrany, RH Weenig, KK Lee, MR...
JCO Early Release, published online ahead of print Dec 5 2005 Journal of Clinical Oncology, 10.1200/JCO.2005.01.9679 This Article Received April 7, 2005 ...
Journal of the National Cancer Institute, Vol. 97, No. 23, 1781-1785, December 7, 2005 DOI: 10.1093/jnci/dji404 BRIEF COMMUNICATION OSW-1: a Natural Compound...
This appears to be a 'repeat' of the original publication that I posted here a while back. This is indeed an interesting drug, but apart from a few posts on ...
New Approach May Allow Vaccination of Immunosuppressed Patients By Will Boggs, MD NEW YORK (Reuters Health) Nov 23 - A new method, using a CD4+ T cell- ...
Scott: Yes, it does appear to be a repeat of your April 2004 article. A year plus with no further developments, yet it does look promising as you say. Do you...
Blood First Edition Paper, prepublished online December 8, 2005; DOI 10.1182/blood-2005-07-2615. This Article Submitted July 1, 2005 Accepted November 15, 2005...
Studies of Nipent in Combination Cancer Therapies for Treatment of Chronic Lymphocytic Leukemia and Graft-versus Host Disease (GVHD) Presented at American...
JCO Early Release, published online ahead of print Dec 12 2005 Journal of Clinical Oncology, 10.1200/JCO.2005.03.1021 This Article Select High-Risk Genetic...
ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B cell chronic lymphocytic leukaemia (B-CLL). Richardson...
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic...
Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia. Rodney E...
A Population-based Assessment of the Prognostic Value of the CD19 Positive Lymphocyte Count in B-cell Chronic Lymphocytic Leukemia using Cox and Markov Models....
[G3139 is Genasense. As is often the case, fine-tuning of the dosing regime et cetera is probably the subject of clinician experimentation. The history of...
[An interesting article. It is interesting to note that this novel gene is associated might produce a protein fragment that is remarkably similar to...
Leukemia. 2005 Dec 8; [Epub ahead of print] Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells. Spaner DE, Shi...
Leukemia. 2005 Dec 8; [Epub ahead of print] Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells. Spaner DE, Shi...
Leukemia. 2005 Dec 8; [Epub ahead of print] TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes...
[Interesting to note that a better anti-CD52 antibody might be possible, more targeted to CLL cells.] Leukemia. 2005 Dec 8; [Epub ahead of print] Alemtuzumab...
[I don't think this study changes much. I suspect from the anecdotal reports that have come out for years will show that there is modest activity for some CLL...
Women Dress for Comfort in the Heat of the Night By MARY DUENWALD Published: December 13, 2005 As fashion trends go, hot flash pajamas are not glamorous. But...
New Genome Project to Focus on Genetic Links in Cancers By ANDREW POLLACK Published: December 14, 2005 The government is beginning a project designed to unlock...
[Note last paragraph in this article] Columbia University Medical Center researchers discover potential mechanism for tumor growth NEW YORK, NY, December 15,...
Cancer. 2005 Dec 13; [Epub ahead of print] Related Articles, Links A retrospective comparison of three sequential groups of patients with Recurrent/Refractory...
Friday, December 16, 2005 Once a rising star, Xcyte hits end of line Core technology sold, merger in works for biotech By JOHN COOK SEATTLE POST-INTELLIGENCER...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
